Suppr超能文献

鉴定作为微小RNA候选靶标的Cyp基因,这些微小RNA的表达受PXR和CAR的代表性配体苯巴比妥(PCN)和TCPOBOP改变。

Identification of Candidate Target Cyp Genes for microRNAs Whose Expression Is Altered by PCN and TCPOBOP, Representative Ligands of PXR and CAR.

作者信息

Moriya Nozomu, Kataoka Hiromi, Nishikawa Jun-Ichi, Kugawa Fumihiko

机构信息

Department of Biopharmaceutics, Hyogo University of Health Sciences.

出版信息

Biol Pharm Bull. 2016 Aug 1;39(8):1381-6. doi: 10.1248/bpb.b16-00279. Epub 2016 May 24.

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that are involved in mRNA post-transcriptional regulation. The deregulation of miRNAs affects the expression of drug-metabolizing enzymes, drug transporters, and nuclear receptors, all of which are important in regulating drug metabolism. miRNA expression can be altered by several endogenous or exogenous agents, such as steroid hormones, carcinogens, and therapeutic drugs. However, it is unclear whether hepatic miRNA expression is regulated by nuclear receptors, such as pregnane X receptor (PXR) and constitutive androstane receptor (CAR), which are indispensable for the expression of the CYPs. Here we investigated the effects of the mouse PXR and CAR ligands pregnenolone-16α-carbonitrile (PCN) and 1,4-bis[(3,5-dichloropyridin-2-yl)oxy]benzene (TCPOBOP) on hepatic miRNA expression in mice. We found that the expression of 9 miRNAs was increased (>2-fold) and of 4 miRNAs was decreased (>50%) in response to PCN, while TCPOBOP treatment led to the up-regulation of 8 miRNAs and down-regulation of 6 miRNAs. Using several miRNA target prediction algorithms, we found that the predicted target genes included several lesser known Cyp genes (Cyp1a1, Cyp1b1, Cyp2b10, Cyp2c38, Cyp2u1, Cyp4a12a/b, Cyp4v3, Cyp17a1, Cyp39a1, and Cyp51). We analyzed the expression of these genes in response to PCN and TCPOBOP and found changes in their mRNA levels, some of which were negatively correlated with the expression of their corresponding miRNAs, suggesting that miRNAs may play a role in regulating Cyp enzyme expression. Further studies will be required to fully elucidate the miRNA regulatory mechanisms that contribute to modulating CYP expression.

摘要

微小RNA(miRNA)是参与mRNA转录后调控的小非编码RNA。miRNA的失调会影响药物代谢酶、药物转运体和核受体的表达,所有这些在调节药物代谢中都很重要。miRNA的表达可被多种内源性或外源性因素改变,如甾体激素、致癌物和治疗药物。然而,尚不清楚肝脏miRNA的表达是否受核受体调控,如孕烷X受体(PXR)和组成型雄甾烷受体(CAR),它们对细胞色素P450(CYP)的表达不可或缺。在此,我们研究了小鼠PXR和CAR的配体孕烯醇酮-16α-腈(PCN)和1,4-双[(3,5-二氯吡啶-2-基)氧基]苯(TCPOBOP)对小鼠肝脏miRNA表达的影响。我们发现,PCN处理后,9种miRNA的表达增加(>2倍),4种miRNA的表达降低(>50%),而TCPOBOP处理导致8种miRNA上调,6种miRNA下调。使用几种miRNA靶标预测算法,我们发现预测的靶基因包括几个鲜为人知的Cyp基因(Cyp1a1、Cyp1b1、Cyp2b10、Cyp2c38、Cyp2u1、Cyp4a12a/b、Cyp4v3、Cyp17a1、Cyp39a1和Cyp51)。我们分析了这些基因对PCN和TCPOBOP的反应表达,发现它们的mRNA水平发生了变化,其中一些与相应miRNA的表达呈负相关,这表明miRNA可能在调节Cyp酶表达中发挥作用。需要进一步研究以充分阐明有助于调节CYP表达的miRNA调控机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验